
Halidou Tinto
Professor Halidou Tinto is the head of the Clinical Research Unit of Nanoro in Burkina Faso, renowned for his groundbreaking work in malaria research. Under his leadership, the unit has gained international recognition for developing innovative solutions to combat malaria, including the first malaria vaccine with a remarkable efficacy rate of 77% and a new rapid test capable of detecting asymptomatic carriers of the malaria parasite. Tinto's personal experience with malaria and his commitment to addressing this deadly disease drive his research, which aims to eliminate malaria in Africa and improve public health outcomes.
Not in the pool (under ¢1).
Recent news mentions
Professor Halidou Tinto is a prominent figure in African research and leads the Clinical Research Unit of Nanoro.
Pr Halidou TINTO: Exemple d’une coopération belgo-burkinabè impactante
Pr Halidou Tinto is the patron of the symposium and shared his vision on the challenges of satisfying healthcare needs.
Gouvernance pharmaceutique : un symposium pour assainir le secteurHalidou Tinto is the head of the clinical research unit in Nanoro and has been instrumental in developing new malaria vaccines.
Pr Halidou Tinto, chef de l’unité de recherches cliniques de Nanoro: « Le nouveau test rapide permet de traquer le parasite du paludisme même dans ses derniers retranchements »


